In 2024, Demir-Dora et al
Furthermore, the study demonstrated that the addition of growth hormone to BPC 157-treated fibroblasts activated Janus kinase 2 (JAK2), a key downstream signaling molecule in the GH receptor pathway
Olson A, Marini F, Westin S, Coleman R, Thall P, Al Jahdami V, Al-Atrash G, Anderlini P, Andersson BS, Alousi A, Ahmed S, Bashir Q, Ciurea S, Hosing C, Im J, Jenq R, Jones R, Kebriaei P, Khouri I, Marin D, Mehta R, Nieto Y, Oran B, Parmar S, Popat U, Qazilbash M, Rezvani K, Timmons M, Champlin RE, Shpall E, Andreeff M
When it comes to dosage this is relative and will depend on your body weight and needs after a physicians evaluation
It is a driver of the disease